Schonfeld Strategic Advisors’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-45,774
| Closed | -$49.9K | – | 2127 |
|
|
2025
Q1 | $49.9K | Buy |
+45,774
| New | +$49.9K | ﹤0.01% | 1942 |
|
|
2024
Q4 | – | Sell |
-16,600
| Closed | -$27.4K | – | 2078 |
|
|
2024
Q3 | $27.4K | Sell |
16,600
-11,600
| -41% | -$19.1K | ﹤0.01% | 1763 |
|
|
2024
Q2 | $31.3K | Sell |
28,200
-24,800
| -47% | -$27.5K | ﹤0.01% | 1839 |
|
|
2024
Q1 | $70K | Sell |
53,000
-76,700
| -59% | -$101K | ﹤0.01% | 1690 |
|
|
2023
Q4 | $195K | Sell |
129,700
-109,000
| -46% | -$164K | ﹤0.01% | 1451 |
|
|
2023
Q3 | $351K | Buy |
238,700
+63,800
| +36% | +$93.8K | ﹤0.01% | 1169 |
|
|
2023
Q2 | $439K | Buy |
174,900
+41,900
| +32% | +$105K | ﹤0.01% | 1232 |
|
|
2023
Q1 | $198K | Buy |
+133,000
| New | +$198K | ﹤0.01% | 1508 |
|
|
2022
Q4 | – | Sell |
-104,400
| Closed | -$330K | – | 2697 |
|
|
2022
Q3 | $330K | Buy |
104,400
+2,700
| +3% | +$8.53K | ﹤0.01% | 1983 |
|
|
2022
Q2 | $353K | Buy |
101,700
+20,700
| +26% | +$71.9K | ﹤0.01% | 1488 |
|
|
2022
Q1 | $916K | Buy |
81,000
+24,700
| +44% | +$279K | 0.01% | 979 |
|
|
2021
Q4 | $539K | Buy |
56,300
+1,900
| +3% | +$18.2K | ﹤0.01% | 1155 |
|
|
2021
Q3 | $482K | Buy |
54,400
+3,500
| +7% | +$31K | 0.01% | 1219 |
|
|
2021
Q2 | $624K | Buy |
50,900
+8,800
| +21% | +$108K | 0.01% | 1049 |
|
|
2021
Q1 | $671K | Buy |
42,100
+2,500
| +6% | +$39.8K | 0.01% | 1003 |
|
|
2020
Q4 | $605K | Sell |
39,600
-51,800
| -57% | -$791K | 0.01% | 945 |
|
|
2020
Q3 | $1.7M | Buy |
91,400
+55,500
| +155% | +$1.03M | 0.03% | 519 |
|
|
2020
Q2 | $435K | Buy |
+35,900
| New | +$435K | 0.01% | 818 |
|